Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides links to updates and FAQs.SummaryDifference0.8%

- Check35 days agoChange DetectedThe site footer now identifies the software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history and the previous v3.6.6 entry was removed, indicating an update to the platform version shown in the history list.SummaryDifference0.1%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.